case_images: PMC10032428_01
case_images: PGM1 monitoring index (PGM1-TMI)
  
   of transferrin biomarkers for select patients in the case series.. For patients 1, 3, and 5, the PGM1-TMI pre-galactose treatment (gray bars)
  and at last clinical follow-up (patterned bars) is shown demonstrating
  improvement in transferrin glycosylation. Patients 2 and 4 were excluded.
  Patient 2 discontinued galactose treatment. Patient 4 did not have a
  pretreatment sample available for analysis. Refer to Supplementary
  Information for more details.
case_images: 10.1177_26330040221150269-fig1.jpg
case_images: PMC10032428_05_10.1177_26330040221150269-fig1.jpg
case_images: fig1-26330040221150269
case_images: Serum transferrin glycosylation improved on D-gal as well (Figure 1).
case_images: PMC10032428_02
case_images: PMC10032428_03
case_images: PGM1 monitoring index (PGM1-TMI)
  
   of transferrin biomarkers for select patients in the case series.. For patients 1, 3, and 5, the PGM1-TMI pre-galactose treatment (gray bars)
  and at last clinical follow-up (patterned bars) is shown demonstrating
  improvement in transferrin glycosylation. Patients 2 and 4 were excluded.
  Patient 2 discontinued galactose treatment. Patient 4 did not have a
  pretreatment sample available for analysis. Refer to Supplementary
  Information for more details.
case_images: 10.1177_26330040221150269-fig1.jpg
case_images: PMC10032428_05_10.1177_26330040221150269-fig1.jpg
case_images: fig1-26330040221150269
case_images: Serum transferrin glycosylation improved on D-gal as well (Figure 1).
case_images: PMC10032428_04
case_images: PMC10032428_05
case_images: PGM1 monitoring index (PGM1-TMI)
  
   of transferrin biomarkers for select patients in the case series.. For patients 1, 3, and 5, the PGM1-TMI pre-galactose treatment (gray bars)
  and at last clinical follow-up (patterned bars) is shown demonstrating
  improvement in transferrin glycosylation. Patients 2 and 4 were excluded.
  Patient 2 discontinued galactose treatment. Patient 4 did not have a
  pretreatment sample available for analysis. Refer to Supplementary
  Information for more details.
case_images: 10.1177_26330040221150269-fig1.jpg
case_images: PMC10032428_05_10.1177_26330040221150269-fig1.jpg
case_images: fig1-26330040221150269
case_images: Serum transferrin glycosylation improved on D-gal as well (Figure 1).